No Data
Guanze Delays Composite Offer Document for Pending Cash Takeover Bid
H Share Movement | GUANZE MEDICAL (02427) Resumed Trading with an Opening Surge of Over 15% Following a Full Takeover Offer from Fude (Hong Kong) Investment Holdings at an Approximately 84% Discount
GUANZE MEDICAL (02427) resumed trading with an opening price more than 15% higher. As of the time of writing, it rose by 15.38%, reaching HKD 1.8, with a turnover of HKD 2.106 million.
GUANZE MEDICAL (02427.HK) resumed trading this morning.
Gronk Holdings announced on February 12 that the shares of GUANZE MEDICAL (02427.HK) will resume trading at 9:00 a.m. today (February 12, 2026).
GUANZE MEDICAL (02427) received a cash offer from Fude (Hong Kong) Investment Holdings at a discount of approximately 84.0%. Trading will resume on February 12.
GUANZE MEDICAL (02427) and the offeror, Fude (Hong Kong) Investment Holdings Co., Ltd., jointly announced that the board was informed by the selling shareholder that on January 28, 2026, the offeror (as the buyer) entered into a sale and purchase agreement with the selling shareholder, Meng A Capital Limited (as the seller), to acquire 699 million shares from the selling shareholder, representing approximately 73.60% of the total issued share capital of the company as of the date of this joint announcement. The total consideration amounts to HKD 175 million (equivalent to a per-share price of HKD 0.25).
GUANZE MEDICAL (02427.HK) received an off-exchange increase of 699 million ordinary shares by FUNDE (HONG KONG) INVESTMENT HOLDINGS CO., LIMITED and its affiliates, valued at approximately HKD 175 million.
According to a report on February 2, as disclosed in a document released by the Hong Kong Stock Exchange on February 2, FUNDE (HONG KONG) INVESTMENT HOLDINGS CO., LIMITED purchased 699 million ordinary shares of $GUANZE MEDICAL(02427.HK)$ over-the-counter at an average price of 0.25 Hong Kong dollars per share on January 28, with a total value of approximately 175 million Hong Kong dollars. Following the increase, FUNDE (HONG KONG) INVESTMENT HOLDINGS CO., LIMITED now holds
GUANZE MEDICAL(02427): Meng A Capital plans to sell approximately 73.6% of the company's shares.
GUANZE MEDICAL (02427) announced that on January 28, 2026, Meng A Capital entered into a sale and purchase agreement with FUNDE (HONG KONG) INVESTMENT HOLDINGS CO., LIMITED (the buyer). Under the agreement, Meng A Capital has conditionally agreed to sell, and the buyer has conditionally agreed to purchase 699 million shares, representing approximately 73.60% of the company's total issued share capital (potential disposal).